Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CTMX compared with VRDN: revenue, margins and what each company keeps, and the suppliers and customers both name
CTMX
CytomX Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
VRDN
Viridian Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CTMX
CytomX Therapeutics, Inc.
vs
VRDN
Viridian Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CTMX, solid
VRDN, dashed
CTMX
CytomX Therapeutics, Inc.
Change
2.35
· pre 2.37
· delayed
Mkt cap
$509.9M
Revenue
$1M
Q2 FY26
Revenue
$76M
FY25
VRDN
Viridian Therapeutics, Inc.
Change
24.69
· pre 24.69
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$2.8B
Revenue
$284,000
Q2 FY26
Revenue
$71M
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
CTMX
CytomX Therapeutics, Inc.
vs
VRDN
Viridian Therapeutics, Inc.
2.35
pre 2.37
delayed
Price
24.69
pre 24.69
delayed
$509.9M
Mkt cap
$2.8B
Q2 FY26
$1M
Revenue
$284,000
Q2 FY26
FY25
$76M
Revenue
$71M
FY25
Change
Change
CTMX
2.35
vs
VRDN
24.69
Pre-market
Oct 30 '26
delayed